Key result
Type 1 diabetes is linked to ~54% higher plasma LMW fluorophore levels, driven by microvascular complications.
Why the study?
The utility of characteristic tissue fluorescence associated with AGE accumulation in patients with type 1 diabetes remains to be established.
Are plasma low-molecular weight fluorophore levels elevated in patients with type 1 diabetes compared to healthy controls, and do they correlate with microvascular complications?
Case-Control (n=225)
Are plasma low-molecular weight fluorophore levels elevated in patients with type 1 diabetes compared to healthy controls, and do they correlate with microvascular complications?
Absolute Event Rate: 6.3% vs 4.1%
p-value: p=0.007
Elevated plasma low-molecular weight fluorophores in type 1 diabetes are associated with microvascular complications and renal function rather than diabetes itself.
No takes yet. Share an insight, caveat, or question.
Supports biomarker research in type 1 diabetes microvascular disease; leaves open causality, prediction, and any clinical role.
Januszewski et al. (2005) conducted a case-control in Type 1 Diabetes Mellitus (n=225). Type 1 diabetes mellitus vs. Healthy age-matched control subjects was evaluated on Plasma low-molecular weight (LMW) fluorophore levels (p=0.007). Type 1 diabetes was associated with higher plasma low-molecular weight fluorophore levels compared to healthy controls (6.3 vs 4.1 AU/mL; P=0.007), driven by patients with microvascular complications.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: